# A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001

> **NCT04945226** · PHASE1,PHASE2 · COMPLETED · sponsor: **Inventage Lab., Inc.** · enrollment: 40 (actual)

## Conditions studied

- Androgenetic Alopecia

## Interventions

- **DRUG:** Finasteride 1mg Tablet
- **DRUG:** IVL3001

## Key facts

- **NCT ID:** NCT04945226
- **Lead sponsor:** Inventage Lab., Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-21
- **Primary completion:** 2022-02-08
- **Final completion:** 2022-02-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04945226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04945226, "A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04945226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*